Dr. WorldWide | Frank Agullo, MD

BLOG

Every plastic surgeon has had the same conversation a thousand times across a desk. The patient is in for a consultation about a planned operation. The operation is well-understood, the indication is clear, the plan is in place, and then the patient asks, quietly, almost as an afterthought, the question that turns out to matter most. What is the scar going to look like.

The honest answer, for years, has been a list of variables that the surgeon controls only partially, layered on top of a list of variables, like genetics and skin type, that the surgeon does not control at all. That answer has been mostly true. It has also been incomplete, because one of the variables sitting right at the surgeon’s hand has been almost entirely absent from the conversation.

The variable is the blade itself. A 114-patient clinical study I served as a principal investigator on, picked up by MPO Magazine in early 2025 under the headline “Significant Reduction in Hypertrophic Scarring Seen With Planatome’s Surgical Blades,” put a hard number on what I had been suspecting in my own practice for years. A cleaner cut produces a quieter scar.

This is the longer surgeon-to-surgeon version of that finding, and what it means for the consultation that starts with “what is my scar going to look like.”

The Study, in One Paragraph

I co-led the 114-patient clinical study evaluating the Planatome surgical blade alongside Michael Sanchez, PhD. The Planatome blade is manufactured with a polishing process that produces a smoother, sharper cutting edge than a standard surgical blade. The study followed patients through standardized incisions and assessed scar quality at multiple time points. The headline finding was a measurable reduction in hypertrophic scarring in the Planatome arm. The trade industry coverage called the reduction significant. I will let other investigators replicate the finding on other populations and in other operations before I make stronger claims, but the result is internally consistent and clinically meaningful.

Why a Cleaner Cut Produces a Quieter Scar

The wound healing cascade begins the moment the blade enters the skin. The depth of the cellular insult at the incision edge is one of the largest single inputs into the inflammatory response that follows. A standard surgical blade, even a brand-new one straight out of the package, has microscopic irregularities along the cutting edge that are functionally invisible to the surgeon at the time. Under a high-magnification image, those irregularities tear the tissue along the incision rather than cleanly transecting it. The cells along the wound edge respond not to the surgeon’s intent but to the cellular environment they are actually in.

A polished, sharper edge produces a different cellular environment. The cells along the incision are cleanly transected rather than crushed. The local inflammatory cascade is quieter. The fibroblast recruitment, the collagen deposition, and the final remodeling that produces the mature scar all start from a different baseline. In the patient who would have formed a flat, fine scar under almost any technique, the difference is invisible because the result was always going to be good. In the patient who would have formed a raised, thickened, hypertrophic scar under any technique, the quieter starting point shifts the curve.

This is the kind of finding that, in retrospect, looks obvious. A sharper knife should produce a cleaner cut and a quieter cellular environment. The reason we needed a study to confirm it is that “obvious” is the most dangerous word in medicine, and the difference between intuition and data is the difference between marketing and a recommendation a surgeon can stand behind.

What the Study Did Not Claim

The study did not claim that blade quality is the only variable in scar formation. It did not claim that a sharper blade will turn a keloid-prone patient into a fine-line healer. It did not claim that the blade matters more than the closure technique, the incision design, the tension on the wound, or the genetics the patient brought with her.

It did claim that, holding the other variables steady, the edge of the blade itself moves the needle. That is a meaningful claim. It is not the only claim.

What I Tell Patients at the Consult

Scar quality is decided across six decisions and one variable I do not control.

The variable I do not control is the patient. Genetics, skin type, anatomic risk, and personal scar history all enter the room with her.

The six decisions are mine. The incision location. The incision orientation. The incision length. The blade. The closure plan, including the layers and the suture choice. The post-operative scar care plan, including silicone, compression, sun protection, and any post-op laser or microneedling on indication.

A sharper blade is the easiest of those six decisions to make. The hardest is honest expectation setting with the patient about what her skin will actually do, regardless of any decision I make.

Where This Lands in Practice

I use the Planatome blade in operations where scar quality is most consequential, including breast augmentation, tummy tuck, mommy makeover, facelift, and any operation on a patient at elevated risk for hypertrophic or keloid scarring.

I also use the study’s existence at the consultation. The patient who wants to know what can be done to give her the cleanest possible scar gets a real answer rather than a vague reassurance, and the answer includes a study I helped design rather than a generic platitude about being careful with the incision.

The trade industry coverage in MPO Magazine framed the result as significant. I would agree. I would also frame it as one of several variables a surgeon can and should optimize for scar quality, and the variable that is easiest to control. The reason it took a 114-patient study to put the finding on the record is that the field genuinely needed the data.

A Brief Word on What the Field Should Do Next

The Planatome study is one data point in a larger conversation about how blade geometry, blade manufacturing, and blade sharpness interact with the inflammatory cascade and the final scar. The questions worth answering next are predictable. Does the effect hold across all skin types and all anatomic locations. Does it hold for procedures that involve electrocautery for the deeper dissection but a cold blade for the initial skin incision. Does it interact with newer scar management modalities, like silicone alternatives, post-op fractional laser, and microneedling at the right interval.

Other investigators will answer those questions in time. The study I co-led is the floor for that work, not the ceiling.

How I Talk About the Whole Scar Equation

When a patient asks “what is my scar going to look like” at a consultation, the honest answer takes ten minutes. It is the most useful ten minutes of the consultation, because the scar is the part of the operation she will see in the mirror for the rest of her life. The plan we make about the scar is the plan we make about her relationship to the result of the operation.

The blade is one part of that ten minutes. The study makes it possible to discuss the blade as a variable backed by real data rather than as a vague reassurance about surgical care. The rest of the ten minutes is still about the patient, the operation, the closure, the post-op plan, and the contingency plan if the scar does not behave the way we hope.

Ready to Talk?

If a planned operation is on your mind and the scar is part of what you are weighing, the first conversation is a consultation. The ten minutes about the scar will be the most useful ten minutes of the visit.

For the clinical patient-facing version of this conversation, see A Sharper Edge: How Blade Geometry Reduces Hypertrophic Scarring on agulloplasticsurgery.com. For the practice-program version of the scar management continuum, see The Scar Management Program at Southwest Plastic Surgery.

Call (915) 590-7900, text 1-866-814-0038, or book online at agulloplasticsurgery.com. #StayBeautiful.

@RealDrWorldWide on Instagram, TikTok, and Snapchat, @Agullo on X, or @AgulloPlasticSurgery on Facebook.

BLOG

Australia’s GP-trade journal, Medical Republic, opened a piece on me last month with the line above, and I will admit to laughing out loud when the alert hit my phone. The piece, titled “Jingle bells, your butt smells,” reprinted the four-bullet post-operative hygiene protocol I wrote for Brazilian Butt Lift patients, credited me as a founding vice-president of the World Association of Gluteal Surgeons, and pushed the conversation out of the back rooms of the practice and into the GP literature halfway around the world.

The reason it traveled is that the topic genuinely is one of the least discussed parts of BBL recovery. The reason I wrote the protocol down in the first place is that nearly every BBL patient in my practice eventually asks me a quieter version of the same question. So here is the longer surgeon-to-surgeon version of the protocol, with the clinical reasoning behind each step.

What the Inside of a Fresh BBL Looks Like at Week Two

A BBL is two operations done together. A liposuction harvest from the donor sites, which can include the abdomen, the flanks, the back, the lower back, the inner thighs, and any other compartment from which the fat has been planned. And a structured gluteal injection, in which the harvested and processed fat is distributed in the subcutaneous compartment of the gluteal region using anatomic, low-pressure cannula technique that respects the safe planes.

By week two, the patient is in the compression garment most of the day. She is sleeping prone or side-lying. She is restricted from sitting in the conventional way. Sweating is increased because the garment is occlusive. Lymphatic fluid is weeping slowly through the small liposuction port incisions. The perineum and the intergluteal cleft are spending most of the day inside a humid, occluded, bacterially friendly environment.

That environment, without disciplined hygiene, produces three predictable problems. A surface odor. A surface skin breakdown. And, in the worst case, a low-grade bacterial colonization of an incision that should have closed cleanly. The patient experiences all three as a single, embarrassing question she does not want to ask out loud, and the answer to that question is a protocol she can run at home.

The Four-Part Protocol, With the Why

Chlorhexidine (Hibiclens) as a Body Wash, Days One Through Twenty-One

Hibiclens is a chlorhexidine gluconate antibacterial wash widely used in pre-operative skin preparation. It has a meaningful residual antibacterial effect on the skin after rinsing, which means the protective effect carries past the shower into the hours when the patient is back in the compression garment. For BBL patients, the perineum and intergluteal cleft are the highest-risk zones in the first two weeks, and a daily Hibiclens wash to that area measurably reduces the bacterial load on the skin without requiring a prescription.

Above the neck, normal soap. Off the eyes, the ears, and any frankly broken or rashy skin. In the small subset with a chlorhexidine sensitivity, substitute a different antibacterial wash, but in my practice the substitution is rare and the protocol holds.

Bidet for the Perineum and the Intergluteal Cleft

Toilet paper after a BBL is abrasive, leaves residue, and tends to drag through tissue that has been freshly operated on. A bidet (full installed unit, sprayer attachment, or a peri-bottle, in that order of luxury) rinses without abrading. The compression garment then goes back on over genuinely clean tissue. Dry gently with a soft towel after the rinse. The same hardware that fifty percent of new mothers swear by after a vaginal delivery serves the same function after a BBL.

Two Compression Garments in Rotation, Washed Daily

This is the change with the largest single effect on odor and on incision-site comfort. Own two garments. Wear one. Wash one. Rotate every twenty-four hours. Cold to warm wash with a gentle detergent. No fabric softener. Flat air dry. Dryer heat tends to break down the medical-grade fabric over time. Patients who try to run a single garment for the entire six weeks discover that the inside of the garment is doing a lot of the work the protocol is supposed to be preventing.

Post-Operative Manual Lymphatic Drainage by an Experienced Therapist

Two to three sessions a week for the first two weeks, weekly through week six, tapering through week twelve. The technique mobilizes lymphatic fluid out of the donor sites and the gluteal compartment along the body’s natural drainage pathways. The recognized benefits, less swelling, faster bruise resolution, less fibrosis, better contour at six weeks, are the headline reasons. The hygiene-related benefit, which is less discussed but real, is that a well-drained donor site is a less hospitable environment for low-grade skin colonization than a poorly drained one.

The Protocol at a Glance

Why the World Association of Gluteal Surgeons Exists

I serve as a founding vice-president of the World Association of Gluteal Surgeons. The organization was founded because the BBL became, very rapidly, one of the most commonly performed aesthetic body procedures in the world, and the field needed an organized peer body that could push safety standards, training standards, and post-operative care standards across borders. The hygiene protocol is one of a series of standards that exist because the early operation, while transformative, was also producing avoidable post-operative problems that better technique and better aftercare could prevent.

Ultrasound-guided injection has been the largest single safety advance in BBL technique in the past five years. The hygiene protocol is one of the largest single comfort-and-infection advances in BBL aftercare. Neither is exotic. Both are now table stakes.

What This Protocol Does Not Replace

It does not replace the antibiotic course if one has been prescribed. It does not replace the surgical follow-up cadence. It does not replace the position restrictions and the activity restrictions of the early weeks. And it does not replace a phone call to the operating surgeon if any of the warning signs appear: a fever above 100.4 F, focal redness, swelling, increasing pain, or a frank wound discharge. The protocol is the layer on top of the surgical plan that quietly prevents the problems nobody wants to discuss out loud. The surgical plan, the follow-up, and the patient’s communication with the operating surgeon are still primary.

How I Built the Protocol

I built the protocol the same way every honest piece of clinical guidance gets built. By doing a high volume of the operation, by listening to the patients who came to follow-up visits, and by writing down the steps that, repeated reliably, eliminated the problems they kept describing. By the time the Medical Republic piece picked it up, the protocol had been in my recovery handout for years and the GP author had simply found that handout via the BBL recovery post on my practice site.

It is short. It is repeatable. It costs almost nothing in dollars. And it does as much work as any peri-operative antibiotic in keeping a BBL recovery on the curve the patient expected when she scheduled the operation.

Ready to Talk?

If a BBL is on your mind and you want to know what a serious recovery plan looks like before you book the operation, the first step is a consultation. The protocol is part of the plan from the beginning, not a handout at discharge.

For the clinical patient-facing version, see What Nobody Tells You About BBL Recovery on agulloplasticsurgery.com. For the practice-program version with the in-house recovery support, see The BBL Recovery Program at Southwest Plastic Surgery.

Call (915) 590-7900, text 1-866-814-0038, or book online at agulloplasticsurgery.com. #StayBeautiful.

@RealDrWorldWide on Instagram, TikTok, and Snapchat, @Agullo on X, or @AgulloPlasticSurgery on Facebook.